Optimized treatment and heart rate reduction in chronic heart failure;Tratamento otimizado e redução da frequência cardíaca na insuficiência cardíaca crônica

Arquivos Brasileiros de Cardiologia

Volumn 101, Issue 5, 2013, Pages 442-447

  Moreno, Irineu Blanco ^a   Del Carlo, Carlos Henrique ^a   Pereira Barretto, Antônio Carlos ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Digoxin; Heart failure; Heart rate; Left; Ventricular dysfunction

Indexed keywords

BISOPROLOL; CANDESARTAN; CAPTOPRIL; CARVEDILOL; ENALAPRIL; LOSARTAN; METOPROLOL SUCCINATE; RAMIPRIL; SPIRONOLACTONE; VALSARTAN;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DRUG EFFICACY; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE VARIABILITY; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; SINUS RHYTHM; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHRONIC DISEASE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE, SYSTOLIC; HEART RATE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; STATISTICS, NONPARAMETRIC;

EID: 84890648849     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.5935/abc.20130201     Document Type: Article

References (25)

1. Barretto AC, Del Carlo CH, Cardoso JN, Morgado PC, Munhoz R T, Eidecols MO. Re-hospitalizações e morte por insuficiência cardíaca. Índices ainda alarmantes. Arq Bras Cardiol. 2008;91(5):335-341.
2. Bocchi EA, Marcondes-Braga FG, Ayub-Ferreira SM, Rohde LE, Oliveira WA, Almeida DR, et al.; Sociedade Brasileira de Cardiologia. III Diretriz brasileira de insuficiência cardíaca crônica. Arq Bras Cardiol. 2009;93(1 supl.1):1-71.
3. Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, van Veldhuisen DJ, Erdmann E, et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J. 2005;26(16):1653-1659.
4. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, et al; Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J. 2003;24(5):464-474.
5. Koelling TM, Johnson ML, Cody RJ, Aaronson KD. Discharge education improves clinical outcomes in patients with chronic heart failure. Circulation. 2005;111(2):179-185.
6. Roccaforte R, Demers C, Baldassarre F, Teo KK, Yusuf S. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients: a meta-analysis. Eur J Heart Fail. 2005;7(7):1133-1144.
7. Barretto AC, Wajngarten M, Serro-Azul JB, Pierri H, Nussbacher A, Gebara OC. Tratamento medicamentoso da insuficiência cardíaca em hospital terciário de São Paulo. Arq Bras Cardiol. 1997;69(6):375-379.
8. Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, et al; SHIFT investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376(9744):875-885. Erratum in: Lancet. 2010;376(9757):1988.
9. Bocchi EA, Marcondes-Braga FG, Bacal F, Ferraz AS, Albuquerque D, Rodrigues D, et al; Sociedade Brasileira de Cardiologia. Atualização da Diretriz Brasileira de insuficiência cardíaca crônica - 2012. Arq Bras Cardiol. 2012;98(1 supl 1):1-33.
10. Fonarow GC, Heywood T, Heidenreich PA, Lopatin M, Yancy CW; ADHERE Scientific Advisory Committee and Investigators. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2007;153(6):1021-1028.
11. Düngen HD, Apostolovic S, Inkrot S, Tahirovic E, Töpper A, Mehrhof F, et al; CIBIS-ELD investigators and Project Multicentre Trials in the Competence Network Heart Failure. Titration to target dose of bisoprolol vs carvedilol in elderly patients with heart failure: the CIBIS-ELD trial. Eur J Heart Fail. 2011;13(6):670-680.
12. Swedberg K, Komajda M, Bohm M, Borer J, Robertson M, Tavazzi L, et al; SHIFT investigators. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of betablocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study. J Am Coll Cardiol. 2012;59(22):1938-1945.
13. Bristow MR, Gilbert EM, Abraham WT, Adams K F, Fowler MB, Hershberger RE, et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation. 1996;94(11):2807-2816.
14. Colucci WS, Kolias TJ, Kirkwood FA, Adams K F, Armstrong W F, Ghali JK, Gottlieb SS, et al; REVERT Study Group. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with toprol-XL (REVERT) trial. Circulation. 2007;116(1):49-56.
15. The Cardiac insufficiency Bisoprolol study II (CIBIS-II): a randomised trial. Lancet. 1999;353(9146):9-13.
16. Willenheimer R, van Veldhuisen DJ, Silke B, Erdmann E, Follath F, Krum H, et al; CIBIS III Investigators. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized cardiac insufficiency bisoprolol study (CIBIS) III. Circulation. 2005;112(16):2426-2435.
17. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, et al; SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26(3):215-225.
18. Fiuzat M, Wojdyla D, Kitzman D, Fleg J, Keteyian SJ, Kraus WE, et al. Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: a Controlled Trial Investigating Outcomes of Exercise Training) trial. J Am Coll Cardiol. 2012;60:208-215.
19. Silva C P, Del Carlo CH, Oliveira Jr MT, Scipioni A, Strunz-Cassaro C, Ramirez JA, et al. Por que os portadores de cardiomiopatia chagásica têm pior evolução que os não chagásicos? Arq Bras Cardiol. 2008;91(6):389-394.
20. Pereira-Barretto AC, Carlo CH, Cardoso JN, Ochiai ME, Lima M V, Curiati MC, et al. Papel dos níveis de BNP no prognóstico da IC avançada descompensada. Arq Bras Cardiol. 2013;100(3):281-287.
21. Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9641):807-816.
22. Castagno D, Skali H, Takeuchi M, Swedberg K, Yusuf S, Granger CB, et al; CHARM Investigators. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program. J Am Coll Cardiol. 2012;59(20):1785-1795.
23. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med. 1997;336(8):525-533.
24. Cullington D, Goode KM, Clark AL, Cleland JG. Heart rate achieved or beta-blocker dose in patients with chronic heart failure: which is the better target? Eur J Heart Fail. 2012;14(7):737-747.
25. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola V P, et al; EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27(22):2725-2736.